9 LEDGIN-mediated inhibition of the IN-LEDGF/p75 interaction reduces provirus reactivation from latency

• Zeger Debyser,
• Gerlinde Vansant,
• Anne Bruggemans,
• Lenard Vranckx,
• Rik Gijsbers,
• Frauke Christ

Affiliations

Zeger Debyser

Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Flanders, Belgium

Gerlinde Vansant

Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Flanders, Belgium

Anne Bruggemans

Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Flanders, Belgium

Lenard Vranckx

Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Flanders, Belgium

Rik Gijsbers

Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Flanders, Belgium

Frauke Christ

Laboratory of Molecular Virology and Gene Therapy, Department of Pharmacological and Pharmaceutical Sciences, KU Leuven, Flanders, Belgium